Lexatumumab

WikiDoc Resources for Lexatumumab
Articles
Most recent articles on Lexatumumab Most cited articles on Lexatumumab Review articles on Lexatumumab Articles on Lexatumumab in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Lexatumumab Images of Lexatumumab Photos of Lexatumumab Podcasts & MP3s on Lexatumumab Videos on Lexatumumab
Evidence Based Medicine
Cochrane Collaboration on Lexatumumab Bandolier on Lexatumumab TRIP on Lexatumumab
Clinical Trials
Ongoing Trials on Lexatumumab at Clinical Trials.gov Trial results on Lexatumumab Clinical Trials on Lexatumumab at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Lexatumumab NICE Guidance on Lexatumumab NHS PRODIGY Guidance FDA on Lexatumumab CDC on Lexatumumab
Books
Books on Lexatumumab
News
Lexatumumab in the news Be alerted to news on Lexatumumab News trends on Lexatumumab
Commentary
Blogs on Lexatumumab
Definitions
Definitions of Lexatumumab
Patient Resources / Community
Patient resources on Lexatumumab Discussion groups on Lexatumumab Patient Handouts on Lexatumumab Directions to Hospitals Treating Lexatumumab Risk calculators and risk factors for Lexatumumab
Healthcare Provider Resources
Symptoms of Lexatumumab Causes & Risk Factors for Lexatumumab Diagnostic studies for Lexatumumab Treatment of Lexatumumab
Continuing Medical Education (CME)
CME Programs on Lexatumumab
International
Lexatumumab en Espanol Lexatumumab en Francais
Business
Lexatumumab in the Marketplace Patents on Lexatumumab
Experimental / Informatics
List of terms related to Lexatumumab

Overview

Lexatumumab (also known as ETR2-ST01) is a human monoclonal antibody used to treat cancer.

External links

• Official website